CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Israel-Based Clearmind Medicine Offers First Clinical Center for Alcohol Use Disorder Trial

Israel-Based Clearmind Medicine...

Adagene Offers Clinical Trial Collaboration to Evaluate Roche's Standard-of-Care for First-Line Advanced Liver Cancer

Adagene Offers Clinical Trial...

Outsourcing the Potential Laboratory Services To Ensure Maximum Efficacy of Trials

Outsourcing the Potential Laboratory...

Accessing Sensitive Research Data Via European Genome-Phenome Archive(EGA)

Accessing Sensitive Research Data Via...

Boosting Clinical Cooperation for Improved Efficacy of Clinical Trials

Boosting Clinical Cooperation for...

Clinical Trials Climate in EU to Upsurge in the Future

Clinical Trials Climate in EU to...

Top Clinical Lab Equipment and Supply Chain Trends to Watch out for in 2022

Top Clinical Lab Equipment and Supply...

Common Challenges Hampering Clinical Laboratory Services

Common Challenges Hampering Clinical...

Israel-Based Clearmind Medicine Offers First Clinical Center for Alcohol Use Disorder Trial

Israel-Based Clearmind Medicine...

Adagene Offers Clinical Trial Collaboration to Evaluate Roche's Standard-of-Care for First-Line Advanced Liver Cancer

Adagene Offers Clinical Trial...

Outsourcing the Potential Laboratory Services To Ensure Maximum Efficacy of Trials

Outsourcing the Potential Laboratory...

Accessing Sensitive Research Data Via European Genome-Phenome Archive(EGA)

Accessing Sensitive Research Data Via...

Boosting Clinical Cooperation for Improved Efficacy of Clinical Trials

Boosting Clinical Cooperation for...

Clinical Trials Climate in EU to Upsurge in the Future

Clinical Trials Climate in EU to...

Top Clinical Lab Equipment and Supply Chain Trends to Watch out for in 2022

Top Clinical Lab Equipment and Supply...

Common Challenges Hampering Clinical Laboratory Services

Common Challenges Hampering Clinical...

Clinical Software Solutions Architecture for CROs and Pharma Companies

Life Sciences Review | Wednesday, November 24, 2021
Tweet

Leaders in the life sciences business predict a gradual transition to single platform architecture, driving the industry to adopt eClinical software solutions.


Fremont, CA: Due to the COVID-19 pandemic, the industry is moving toward eClinical software solutions that are on unified platforms. Massive volumes of data collection from an increasing number and diverse set of data sources, as well as the need for sponsors and CROs to gain more complete views of trials and act on data quickly, are driving the industry toward eClinical software solutions that are on unified platforms. Organizations that have made the switch to an external eClinical solution provider's platform have looked for ways to justify the move.


The architecture of eClinical software systems for CROs is likely to take one of two forms:


Preferred tech:


These are often huge CROs that sell both their outsourced services and their own technologies in the market. Internal development, acquisitions, or exclusive vendor partnerships may have resulted in the development of these technologies. Although these CROs prefer to utilize and sell their own technology, they also use and sell those of others.


Agnostic:


Although these CROs do not have huge internal infrastructures, they are usually capable of managing data linkages. These businesses may have a favorite eClinical solutions provider, but they will usually follow the client's wishes.


Pharmaceutical/biotech firms' eClinical software solutions architecture is likely to take one of two forms:


Large legacy companies:


Platform architectures are frequently designed wholly or primarily in-house, with a mix of cloud-hosted and in-house integration. These complicated systems come at a premium price, and new application deployments frequently necessitate a rethinking of the existing architecture.


Check Out This: Excelitas Technologies


 


New companies:


A triggering event (such as a merger and acquisition or a new enterprise) frequently prompts the consideration of a new or modified design. In this environment, few companies will invest in internal IT development; instead, they will explore outsourcing their studies to CROs or purchasing an eClinical platform that meets all or most of their requirements. End-to-end coverage and easy interaction with other required capabilities are essential aspects in SaaS systems.


Pharmaceutical companies will continue to evolve and adapt to their increasingly digital environment, moving away from single, fragmented point solutions and toward unified platforms. Embracing unified platforms reduces the burden on clinical development teams, allows sponsors to centralize their data to gain valuable insights across trials instead of dealing with disparate datasets isolated across several point solutions, and allows sponsors to scale to support large numbers of studies.


Weekly Brief

loading

  • Top 10 Clinical Trial Services Companies - 2022
  • Top 10 Emerging Clinical Trial Management Companies - 2022
  • Top 10 Clinical Trial Management System Companies - 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/clinical-software-solutions-architecture-for-cros-and-pharma-companies-nwid-639.html